The Therapeutic Effects of the Radiotherapy Plus TCM Treatment Observed in Senile Non-Parvicellular Lung Cancer Patients at the Late Stage

47 senile non-parvicellular lung cancer patients at stage Ⅲ or Ⅳ were randomly divided into a treatmentgroup (26 cases) treated by radiotherapy plus traditional Chinese medicine (TCM) and a control group (21cases) treated only by radiotherapy for observation of the therapeutic effects.The patients in the treatmentgroup orally took Chinese medicine during and after the radiotherapy.There was no obvious difference inshort-term therapeutic effects between the two groups,but the long-term curative effects in the treatmentgroup was obviously superior to that in the control group (P<0.05 or P<0.01).Conclusion:radiotherapy plusTCM can prolong the survival period for senile non-parvicellular lung cancer patients.     

肾单位化疗损伤和中药防治作用的临床观察

目的观察化疗对肾单位损伤的变化过程和中药的防治作用。方法采用抽签随机分组法将400例化疗前肾功正常的患者分为中药加化疗组（治疗组）和单纯化疗组（对照组）,每组200例,两组均接受30d为一周期的化疗方案,用放免法测定患者化疗不同时期尿液β2-微球蛋白（β2-M）、白蛋白（Alb）和免疫球蛋白G（IgG）,连续观察肾单位损伤的状况和转归。治疗组在化疗前1天口服中药保肾合剂,3次/d,1次150ml,连服15d。对照组按化疗方案需要行常规水化、碱化或氯化。结果两组尿液β2-M,Alb和IgG异常指标均在化疗第7天达高峰,后逐渐下降,21d后大部分患者可恢复正常。治疗组化疗第14、21天转阴率明显高于对照组（P〈0.01）。结论化疗对肾单位的损伤有时间规律可循,处理得当大部分是可逆的。中医药对化疗所致的肾单位损伤有显著防治优势。     

中医药与放化疗治疗晚期肺癌的疗效观察

采用中医药加免疫治疗晚期肺癌 40例 ,与放化疗加免疫治疗、不用中药治疗的晚期肺癌 40例做对照 ,结果表明 ,中医药治疗稳定率较高 ,生存时间较长 ,配合其他疗法是晚期肺癌理想的治疗手段     

中药加放疗治疗老年非小细胞肺癌的疗效分析

目的 观察中药加放疗对老年非小细胞肺癌的疗效.方法 对167例确诊的Ⅰ-Ⅳ期老年非小细胞肺癌病人,随机分为中药加放疗治疗组82例,单纯放疗对照组85例,进行治疗观察,治疗组在放疗同时服用中药,放疗后继服中药巩固治疗.结果 两组近期疗效无明显差异(P＞0.05),远期疗效治疗组明显优于对照组(P＜0.01).结论 提示中药加放疗可延长老年非小细胞肺癌病人的生存期.     

醋酸甲地孕酮在晚期癌症中的应用观察

20 0 0年 3月～ 2 0 0 1年 2月 ,我们应用醋酸甲地孕酮治疗晚期癌症患者 32例 ,与不用甲地孕酮患者 30例对比观察 ,治疗组明显改善了患者的食欲 ,大大提高了患者的生活质量。1　临床资料1.1　一般资料共收治中晚期癌症患者 62例 ,年龄 2 0～ 76岁 ,均经组织学、病理学或临床影像学证实 ,随机分为治疗组 (甲地孕酮组 )与对照组 (不用甲地孕酮组 )。治疗组 32例 ,男 10例 ,女 2 2例 ,平均年龄 5 7 5岁 ( 2 9～ 76岁 ) ,其中肺癌 2 2例 ,胃癌 4例 ,结肠癌 2例 ,乳腺癌 2例 ,胆管癌 2例。对照组 30例 ,男 12例 ,女 18例 ,平均年龄 5 2 5岁 ( 2 …     

Clinical observation on chemical damage of nephron and the preventive and therapeutic effects of Baoshen Mixture (保肾合剂) on it

Objective:To observe the change of nephron damaged by chemotherapy and to evaluate the effect of Baoshen Mixture(保肾合剂,BSM) in protecting and treating damaged nephrons.Methods:Four hundred tumor patients with normal renal function and ready to receive chemotherapy were randomly assigned to two groups.Both groups received one cycle of chemotherapy program of 28-30 days with conventional hydratization,alkalization and chloridization.To the 200 cases in the treated group BSM was given orally thrice a day,150 mL every time for 15 successive days and the other 200 cases in the control group were treated by chemotherapy alone.The clinical efficacy was compared after treatment,and the changed condition of damaged nephrons were monitored dynamically and compared at different time points(the 3rd,7th,14th and 21st day after chemotherapy) by measuring the micro-globulin β2(β2-MG),albumin(Alb) and immunoglobulin G(IgG) levels in urine with radioimmunoassay(RIA).Results:(1) The effective rates in the treated group at the 4 time points of observation were all higher than those in the control group respectively(P<0.05 or P<0.01);(2) Less occurrence of abnormal β2-M,Alb and IgG levels on the 14th and 21st day in the treated group took place compared to that in the control group(P<0.01);(3) Urinary levels of β2-MG,Alb and IgG reached the peak on the 7th day in both groups,and then,they came down gradually and returned to the normal level on the 21st day.However,comparison between the two groups showed that all the three parameters in the treated group on day 3,14 and 21 were lower than the respective one at the corresponding time points in the control group(P<0.05 or P<0.01).Conclusion:The chemotherapy damage on nephron is regular in time,and reversible when treated suitably.TCM shows a marked effect in protecting and treating the damage on nephron caused by chemotherapy.     

醋酸甲地孕酮在晚期癌症中的应用观察

众所周知,晚期癌症病人食欲差,出现消瘦、恶病质、生存质量下降,是临床肿瘤专业医生面临的棘手问题。从2000年3月～2001年2月,我们应用醋酸甲地孕酮治疗晚期癌症病人共32例,与不用甲地孕酮患者30例对比观察,治疗组明显改善了患者的食欲,大大提高了患者的生活质量,现报告如下。 1 临床资料与方法 1.1 一般资料 共收治中晚期癌症62例,年龄20～76岁,均经组织学、病理学或临床影像学证实,随机分为治疗组(甲地孕酮组)与对照组(不用甲地孕酮组)。治疗组32例,平均年龄57.5岁(29～76岁),男女之比为1:2.2,其中,肺癌22例,胃癌4例,结肠癌2例,乳腺癌2例,胆管癌2例。对照组     

实体瘤的脑脊膜转移〔英〕

作者将两组具有相似类别的实体瘤脑脊膜转移病人进行前瞻性治疗。第１组５４例病人采用放疗、脑脊液内化疗和系统化疗；第２组５０名病人采用放疗、系统化疗而不行脑脊液内化疗。治疗结果分析比较显示，行脑脊液内化疗并没有改变反应率、反应持续时间、平均生存期或长期幸...